Stephen T. Schultz,Mauris N. DeSilva,Georgianna G. Gould
申请号：
US13411538
公开号：
US20120225015A1
申请日:
2012.03.03
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The inventive method relates to a method for the determination of susceptibility or diagnosis of autism or autism spectrum disorders. Diagnosis or determination of susceptibility determinations are predicated on quantitative analysis of endocannibinoid levels or endocannibinoid receptor expression.
